Keyphrases
Acute Myeloid Leukemia
100%
Retargeting
100%
Dual-affinity
100%
CD123
100%
T Cells
33%
T Cell Activation
16%
Hematological Malignancies
16%
Tumor Cells
16%
T Cell Receptor
16%
Bispecific Antibody
16%
Polypeptide
16%
Hematopoietic Stem Cells
16%
Dose Effect
16%
T Cell Proliferation
16%
In Tandem
16%
Effector Cells
16%
Target Antigen
16%
Acute Myeloid Leukemia Cells
16%
Normal Hematopoietic Stem Cells
16%
Differentially Expressed
16%
Cell Association
16%
Interleukin
16%
Leukemia Cell Lines
16%
Immunology and Microbiology
Myeloid
100%
Hematopoietic Cell
40%
T Cell
40%
Flotetuzumab
40%
CD3 Antigen
40%
Cytokine
20%
T Cell Activation
20%
Tumor Cell
20%
T Cell Receptor
20%
T Cell Proliferation
20%
Effector Cell
20%
Bispecific Antibody
20%
CD123 Antigen
20%
Acute Myeloid Leukemia Cell Line
20%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Flotetuzumab
33%
CD3 Antigen
33%
Neoplasm
16%
Receptor
16%
Hematologic Malignancy
16%
Cytokine
16%
Bispecific Antibody
16%
Polypeptide
16%
CD123 Antigen
16%